Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Chemotherapy

NCT02049047 is registered in ClinicalTrials.gov with Armando Santoro, MD as lead sponsor.

NCT NCT02049047
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02049047 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Chemotherapy
Lead sponsor
Armando Santoro, MD
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2011
Completion date
January 31, 2019
Enrollment
41 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thymoma and thymic carcinoma